Loading…

Optimizing treatments of locally advanced squamous cell carcinoma: Where to go from here?

Saved in:

Bibliographic Details
Published in:	Oral oncology 2011-10, Vol.47 (10), p.931-933
Main Author:	Bernier, J
Format:	Article
Language:	English
Subjects:	Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal, Humanized Antimetabolites, Antineoplastic - administration & dosage Antineoplastic Agents - administration & dosage Carcinoma, Squamous Cell - therapy Cetuximab Chemoradiation Chemotherapy Cisplatin - administration & dosage Combined Modality Therapy - methods Fluorouracil - administration & dosage Head and neck Head and Neck Neoplasms - therapy Hematology, Oncology and Palliative Medicine Humans Organ preservation Otolaryngology Radiotherapy Randomized Controlled Trials as Topic Sequential treatment Targeted therapy Taxoids - administration & dosage Treatment Outcome
Citations:	Items that this one cites Items that cite this one
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

cited_by	cdi_FETCH-LOGICAL-c434t-8eeae9ba5905892d02007f7a022bc95af7cae7014286cb7ed0dbd632f39681b43
cites	cdi_FETCH-LOGICAL-c434t-8eeae9ba5905892d02007f7a022bc95af7cae7014286cb7ed0dbd632f39681b43
container_end_page	933
container_issue	10
container_start_page	931
container_title	Oral oncology
container_volume	47
creator	Bernier, J
description
doi_str_mv	10.1016/j.oraloncology.2011.07.026
format	article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_898206625</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S1368837511007676</els_id><sourcerecordid>898206625</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-8eeae9ba5905892d02007f7a022bc95af7cae7014286cb7ed0dbd632f39681b43</originalsourceid><addsrcrecordid>eNqNkU1v1DAQhi0Eoh_wF5DFhVPC2Fl_pAcQKhSQKvUACHGyHGeyeHHirZ1UWn49jrYgxInTzEjvfD0vIc8Z1AyYfLmrY7IhTi6GuD3UHBirQdXA5QNyyrRqKxBt87DkjdSVbpQ4IWc57wBAMAGPyQlnWkgO-pR8u9nPfvQ__bSlc0I7jzjNmcaBhuhsCAdq-zs7Oexpvl3sGJdMHYZAnU3OT3G0F_Trd0xI50i3kQ4pjnStXz8hjwYbMj69j-fky9W7z5cfquub9x8v31xXbtNs5kojWmw7K1oQuuU9cAA1KAucd64VdlDOogK24Vq6TmEPfdfLhg9NKzXrNs05eXGcu0_xdsE8m9Hn9UQ7YbnW6FZzkJKLorw4Kl2KOScczD750aaDYWBWsmZn_iZrVrIGlClkS_Oz-zVLN2L_p_U3yiJ4exRgefbOYzLZeVzJ-YRuNn30_7fn1T9jXPCTL178wAPmXVzSVHAaZjI3YD6tHq8WM1a4SSWbX5pepxc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>898206625</pqid></control><display><type>article</type><title>Optimizing treatments of locally advanced squamous cell carcinoma: Where to go from here?</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Bernier, J</creator><creatorcontrib>Bernier, J</creatorcontrib><identifier>ISSN: 1368-8375</identifier><identifier>EISSN: 1879-0593</identifier><identifier>DOI: 10.1016/j.oraloncology.2011.07.026</identifier><identifier>PMID: 21856208</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject><![CDATA[Antibodies, Monoclonal - administration & dosage ; Antibodies, Monoclonal, Humanized ; Antimetabolites, Antineoplastic - administration & dosage ; Antineoplastic Agents - administration & dosage ; Carcinoma, Squamous Cell - therapy ; Cetuximab ; Chemoradiation ; Chemotherapy ; Cisplatin - administration & dosage ; Combined Modality Therapy - methods ; Fluorouracil - administration & dosage ; Head and neck ; Head and Neck Neoplasms - therapy ; Hematology, Oncology and Palliative Medicine ; Humans ; Organ preservation ; Otolaryngology ; Radiotherapy ; Randomized Controlled Trials as Topic ; Sequential treatment ; Targeted therapy ; Taxoids - administration & dosage ; Treatment Outcome]]></subject><ispartof>Oral oncology, 2011-10, Vol.47 (10), p.931-933</ispartof><rights>Elsevier Ltd</rights><rights>2011 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-8eeae9ba5905892d02007f7a022bc95af7cae7014286cb7ed0dbd632f39681b43</citedby><cites>FETCH-LOGICAL-c434t-8eeae9ba5905892d02007f7a022bc95af7cae7014286cb7ed0dbd632f39681b43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21856208$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bernier, J</creatorcontrib><title>Optimizing treatments of locally advanced squamous cell carcinoma: Where to go from here?</title><title>Oral oncology</title><addtitle>Oral Oncol</addtitle><subject>Antibodies, Monoclonal - administration & dosage</subject><subject>Antibodies, Monoclonal, Humanized</subject><subject>Antimetabolites, Antineoplastic - administration & dosage</subject><subject>Antineoplastic Agents - administration & dosage</subject><subject>Carcinoma, Squamous Cell - therapy</subject><subject>Cetuximab</subject><subject>Chemoradiation</subject><subject>Chemotherapy</subject><subject>Cisplatin - administration & dosage</subject><subject>Combined Modality Therapy - methods</subject><subject>Fluorouracil - administration & dosage</subject><subject>Head and neck</subject><subject>Head and Neck Neoplasms - therapy</subject><subject>Hematology, Oncology and Palliative Medicine</subject><subject>Humans</subject><subject>Organ preservation</subject><subject>Otolaryngology</subject><subject>Radiotherapy</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Sequential treatment</subject><subject>Targeted therapy</subject><subject>Taxoids - administration & dosage</subject><subject>Treatment Outcome</subject><issn>1368-8375</issn><issn>1879-0593</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNqNkU1v1DAQhi0Eoh_wF5DFhVPC2Fl_pAcQKhSQKvUACHGyHGeyeHHirZ1UWn49jrYgxInTzEjvfD0vIc8Z1AyYfLmrY7IhTi6GuD3UHBirQdXA5QNyyrRqKxBt87DkjdSVbpQ4IWc57wBAMAGPyQlnWkgO-pR8u9nPfvQ__bSlc0I7jzjNmcaBhuhsCAdq-zs7Oexpvl3sGJdMHYZAnU3OT3G0F_Trd0xI50i3kQ4pjnStXz8hjwYbMj69j-fky9W7z5cfquub9x8v31xXbtNs5kojWmw7K1oQuuU9cAA1KAucd64VdlDOogK24Vq6TmEPfdfLhg9NKzXrNs05eXGcu0_xdsE8m9Hn9UQ7YbnW6FZzkJKLorw4Kl2KOScczD750aaDYWBWsmZn_iZrVrIGlClkS_Oz-zVLN2L_p_U3yiJ4exRgefbOYzLZeVzJ-YRuNn30_7fn1T9jXPCTL178wAPmXVzSVHAaZjI3YD6tHq8WM1a4SSWbX5pepxc</recordid><startdate>20111001</startdate><enddate>20111001</enddate><creator>Bernier, J</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20111001</creationdate><title>Optimizing treatments of locally advanced squamous cell carcinoma: Where to go from here?</title><author>Bernier, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-8eeae9ba5905892d02007f7a022bc95af7cae7014286cb7ed0dbd632f39681b43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Antibodies, Monoclonal - administration & dosage</topic><topic>Antibodies, Monoclonal, Humanized</topic><topic>Antimetabolites, Antineoplastic - administration & dosage</topic><topic>Antineoplastic Agents - administration & dosage</topic><topic>Carcinoma, Squamous Cell - therapy</topic><topic>Cetuximab</topic><topic>Chemoradiation</topic><topic>Chemotherapy</topic><topic>Cisplatin - administration & dosage</topic><topic>Combined Modality Therapy - methods</topic><topic>Fluorouracil - administration & dosage</topic><topic>Head and neck</topic><topic>Head and Neck Neoplasms - therapy</topic><topic>Hematology, Oncology and Palliative Medicine</topic><topic>Humans</topic><topic>Organ preservation</topic><topic>Otolaryngology</topic><topic>Radiotherapy</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Sequential treatment</topic><topic>Targeted therapy</topic><topic>Taxoids - administration & dosage</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bernier, J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Oral oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bernier, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Optimizing treatments of locally advanced squamous cell carcinoma: Where to go from here?</atitle><jtitle>Oral oncology</jtitle><addtitle>Oral Oncol</addtitle><date>2011-10-01</date><risdate>2011</risdate><volume>47</volume><issue>10</issue><spage>931</spage><epage>933</epage><pages>931-933</pages><issn>1368-8375</issn><eissn>1879-0593</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>21856208</pmid><doi>10.1016/j.oraloncology.2011.07.026</doi><tpages>3</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 1368-8375
ispartof	Oral oncology, 2011-10, Vol.47 (10), p.931-933
issn	1368-8375 1879-0593
language	eng
recordid	cdi_proquest_miscellaneous_898206625
source	ScienceDirect Freedom Collection 2022-2024
subjects	Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal, Humanized Antimetabolites, Antineoplastic - administration & dosage Antineoplastic Agents - administration & dosage Carcinoma, Squamous Cell - therapy Cetuximab Chemoradiation Chemotherapy Cisplatin - administration & dosage Combined Modality Therapy - methods Fluorouracil - administration & dosage Head and neck Head and Neck Neoplasms - therapy Hematology, Oncology and Palliative Medicine Humans Organ preservation Otolaryngology Radiotherapy Randomized Controlled Trials as Topic Sequential treatment Targeted therapy Taxoids - administration & dosage Treatment Outcome
title	Optimizing treatments of locally advanced squamous cell carcinoma: Where to go from here?
url	http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T09%3A10%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Optimizing%20treatments%20of%20locally%20advanced%20squamous%20cell%20carcinoma:%20Where%20to%20go%20from%20here?&rft.jtitle=Oral%20oncology&rft.au=Bernier,%20J&rft.date=2011-10-01&rft.volume=47&rft.issue=10&rft.spage=931&rft.epage=933&rft.pages=931-933&rft.issn=1368-8375&rft.eissn=1879-0593&rft_id=info:doi/10.1016/j.oraloncology.2011.07.026&rft_dat=%3Cproquest_cross%3E898206625%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c434t-8eeae9ba5905892d02007f7a022bc95af7cae7014286cb7ed0dbd632f39681b43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=898206625&rft_id=info:pmid/21856208&rfr_iscdi=true